WHO pauses hydroxychloroquine trial over safety concerns
The World Health Organization said that it has suspended its trial of the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook